Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2021
[Features of emotional regulation in children with anxiety disorders].
СтатьяНазвание и аннотация: Оригинал на русском
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Surushkina S Yu, Chutko L S, Yakovenko E A, Anisimova T I, Polskaya A V, Cherednichenko D V
Аннотация
OBJECTIVE: Study of clinical and psychophysiological disorders in preschool children with anxiety disorders and assessment of the effectiveness of Anvifen in the treatment of this pathology.
MATERIAL AND METHODS: The study included 64 children aged 5 to 7 years with a diagnosis of phobic disorder of childhood (F93.1). Clinical, pathophysiological and psychometric research methods were used in the work. Anvifen was used to treat 40 patients from the study group. Patient satisfaction with treatment outcomes was assessed using the Integrative Medicine Patient Satisfaction Scale (IMPSS).
RESULTS: According to the data obtained, in the study group, 76.5% of patients had fear associated with health (infections, illness, death); in 68.6% of cases - fears of the death of parents; in 57.5% of cases - fear of the dark; in 40.6% of cases - fears of loneliness; in 31.2% of cases - fears related to the educational institution; in 28.1% - fear of animals, as well as a lower level of emotional identification and a significantly higher level of impulsivity than in the control group. Sleep disorders were recorded in 87.5% of children from the study group. After the course of treatment, an improvement in the condition was noted in 70.0% of children in the form of a decrease in anxiety, impulsivity and an improvement in falling asleep and a decrease in the number of awakenings.
CONCLUSION: The use of Anvifen leads to a significant improvement in the quality of sleep and a decrease in signs of anxiety before sleep and signs of impaired quality of wakefulness, which allows us to conclude that Anvifen is effective in treating anxiety disorders in children.
MATERIAL AND METHODS: The study included 64 children aged 5 to 7 years with a diagnosis of phobic disorder of childhood (F93.1). Clinical, pathophysiological and psychometric research methods were used in the work. Anvifen was used to treat 40 patients from the study group. Patient satisfaction with treatment outcomes was assessed using the Integrative Medicine Patient Satisfaction Scale (IMPSS).
RESULTS: According to the data obtained, in the study group, 76.5% of patients had fear associated with health (infections, illness, death); in 68.6% of cases - fears of the death of parents; in 57.5% of cases - fear of the dark; in 40.6% of cases - fears of loneliness; in 31.2% of cases - fears related to the educational institution; in 28.1% - fear of animals, as well as a lower level of emotional identification and a significantly higher level of impulsivity than in the control group. Sleep disorders were recorded in 87.5% of children from the study group. After the course of treatment, an improvement in the condition was noted in 70.0% of children in the form of a decrease in anxiety, impulsivity and an improvement in falling asleep and a decrease in the number of awakenings.
CONCLUSION: The use of Anvifen leads to a significant improvement in the quality of sleep and a decrease in signs of anxiety before sleep and signs of impaired quality of wakefulness, which allows us to conclude that Anvifen is effective in treating anxiety disorders in children.